Interference of Dapsone in HbA1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica

Bertholon, Mireille; Mayer, Anne; Francina, Alain; Thivolet, Charles

doi:10.2337/diacare.17.11.1364a

Article navigation

Letters| November 01 1994

Interference of Dapsone in HbA_1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica

Mireille Bertholon, MD;

Mireille Bertholon, MD

Department of Endocrinology, Edouard Herriot Hospital

Lyon, France

Search for other works by this author on:

This Site

PubMed

Google Scholar

Anne Mayer, MD;

Anne Mayer, MD

Department of Endocrinology, Edouard Herriot Hospital

Lyon, France

Search for other works by this author on:

This Site

PubMed

Google Scholar

Alain Francina, D PHARM;

Alain Francina, D PHARM

Department of Biochemistry, Edouard Herriot Hospital

Lyon, France

Search for other works by this author on:

This Site

PubMed

Google Scholar

Charles Thivolet, MD, PHD

Department of Endocrinology, Edouard Herriot Hospital

Lyon, France

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Charles Thivolet, MD, PhD, Service d'Endocrinologie, Pavilion X, Edouard Herriot Hopital, 69003 Lyon, France.

Diabetes Care 1994;17(11):1364

https://doi.org/10.2337/diacare.17.11.1364a

PubMed:

7821184

Interference of Dapsone in HbA_1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Interference of Dapsone in HbA1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Interference of Dapsone in HbA_1c Monitoring of a Type I Diabetic Patient With Necrobiosis Lipoidica